Next Article in Journal
Adjuvant Interferon Alfa for Melanoma
Previous Article in Journal
Balancing Potential Quality-of-Life Benefits Against the Risk of Lethal Late Recurrence with Bladder-Preserving Surgery
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Article

Consensus Recommendations for the Diagnosis and Management of Well-Differentiated Gastroenterohepatic Neuroendocrine Tumours: A Revised Statement from a Canadian National Expert Group

1
London Regional Cancer Centre, London, ON, Canada
2
Ottawa Regional Cancer Centre, Ottawa, ON, Canada
3
BC Cancer Agency, Vancouver, BC, Canada
4
University of Toronto, Toronto, ON, Canada
5
McGill University, Montreal, QC, Canada
6
Centre Hospitalier Universitaire de Quebec, Quebec, QC, Canada
7
University of Western Ontario, London, ON, Canada
8
Sunnybrook Health Sciences Centre, Toronto, ON, Canada
9
St. Joseph’s Health Care, London, ON, Canada
10
University of Manitoba, Winnipeg, MB, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2010, 17(3), 49-64; https://doi.org/10.3747/co.v17i3.484
Received: 1 May 2010 / Revised: 7 May 2010 / Accepted: 14 May 2010 / Published: 1 June 2010
Well-differentiated neuroendocrine tumours (NETS—previously called “carcinoid tumours”) are relatively rare tumours originating from the diffuse neuroendocrine system; they are found most often in the bronchial or gastrointestinal systems. In Canada, gastroenterohepatic NETS represent less than 0.25% of oncology cases. Because of the relative rarity of these tumours, diagnostic and therapeutic approaches vary and are often based on individual physician experience. A number of European and North American groups have developed consensus guidelines for the diagnosis and management of well-differentiated gastroenterohepatic NETS, and in 2006, Canadian consensus guidelines were published by a Canadian expert group. The updated and expanded current Canadian guidelines are based on a consensus meeting held in Paris, France, in 2008 and are based on the most current literature.
Keywords: carcinoid tumour; carcinoid syndrome; carcinoid heart disease; neuroendocrine tumours; guidelines; clinical management; diagnosis; surgery carcinoid tumour; carcinoid syndrome; carcinoid heart disease; neuroendocrine tumours; guidelines; clinical management; diagnosis; surgery
MDPI and ACS Style

Kocha, W.; Maroun, J.; Kennecke, H.; Law, C.; Metrakos, P.; Ouellet, J.F.; Reid, R.; Rowsell, C.; Shah, A.; Singh, S.; Van Uum, S.; Wong, R. Consensus Recommendations for the Diagnosis and Management of Well-Differentiated Gastroenterohepatic Neuroendocrine Tumours: A Revised Statement from a Canadian National Expert Group. Curr. Oncol. 2010, 17, 49-64. https://doi.org/10.3747/co.v17i3.484

AMA Style

Kocha W, Maroun J, Kennecke H, Law C, Metrakos P, Ouellet JF, Reid R, Rowsell C, Shah A, Singh S, Van Uum S, Wong R. Consensus Recommendations for the Diagnosis and Management of Well-Differentiated Gastroenterohepatic Neuroendocrine Tumours: A Revised Statement from a Canadian National Expert Group. Current Oncology. 2010; 17(3):49-64. https://doi.org/10.3747/co.v17i3.484

Chicago/Turabian Style

Kocha, W.; Maroun, J.; Kennecke, H.; Law, C.; Metrakos, P.; Ouellet, J.F.; Reid, R.; Rowsell, C.; Shah, A.; Singh, S.; Van Uum, S.; Wong, R. 2010. "Consensus Recommendations for the Diagnosis and Management of Well-Differentiated Gastroenterohepatic Neuroendocrine Tumours: A Revised Statement from a Canadian National Expert Group" Curr. Oncol. 17, no. 3: 49-64. https://doi.org/10.3747/co.v17i3.484

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop